A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer. [electronic resource]
Producer: 20091008Description: 242-8 p. digitalISSN:- 1879-0461
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab
- Capecitabine
- Carcinoma -- drug therapy
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Neoadjuvant Therapy
- Neoplasm Metastasis
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.